Target intelligence / Profile preview

A-kinase anchoring protein 3 (AKAP3)

Target
AKAP3
Molecular classification
Scaffolding protein, Signal transduction molecule, cAMP signaling organizer, Anchoring protein (A-kinase anchoring protein family), Other (not enzyme, transporter, receptor, ion channel, transcription factor, or histone modifier)
01

Overview

A-kinase anchoring protein 3 (AKAP3) is a member of the A-kinase anchoring protein family, serving as a scaffold for protein kinase A (PKA) and other signaling proteins in sperm cells. Expressed specifically in spermatids and mature spermatozoa, AKAP3 is a key component of the sperm tail's fibrous sheath, interacting with other structural proteins such as AKAP4 and partner proteins like CABYR, ROPN1, and SPA17. AKAP3 enables organization of cAMP-dependent PKA signaling complexes that regulate sperm flagellar structure, motility, capacitation, and acrosome reaction. Genetic mutations or disruptions in AKAP3 can lead to male infertility due to compromised sperm motility and improper formation of the fibrous sheath. While AKAP3 is identified as a cancer/testis antigen, it does not currently serve as a direct therapeutic target and has no known interacting drugs[1][2][3][4].

Other names
AKAP110SOB1CT82FSP95PRKA3Fibrous sheath protein of 95 kDaCancer/testis antigen 82Fibrousheathin IFibrousheathin-1Sperm oocyte-binding proteinHEL159SPGF82epididymis luminal protein 159epididymis secretory sperm binding protein
02

Mechanism of action

No specific drug mechanism against AKAP3 is established, since it is not a classical drug target.

03

Biological functions

Anchoring protein kinase A (PKA) to specific subcellular locationsSperm flagellum structure organizationSperm motility regulationParticipation in sperm capacitation and acrosome reactionFormation of multiprotein signaling complexes
04

Disease associations

Male infertility (abnormal AKAP3 or mutations lead to impaired sperm motility and fibrous sheath abnormalities)Possible association in cancer (classified as a cancer/testis antigen, but not established as causative)
05

Biomarkers

Cancer/testis antigen 82 (CT82, when aberrantly expressed in cancer or as a marker in male infertility research)

Beyond the preview

Go deeper on A-kinase anchoring protein 3 (AKAP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on A-kinase anchoring protein 3 (AKAP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call